Corbus Pharmaceuticals Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $2.61M, a 25.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.61M -$874K -25.1% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.84M -$847K -23% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.06M -$821K -21.1% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $3.28M -$796K -19.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $3.49M -$772K -18.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.69M -$748K -16.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.88M -$725K -15.7% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $4.07M -$702K -14.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.26M -$681K -13.8% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $4.44M -$660K -12.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $4.61M -$639K -12.2% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $4.78M -$620K -11.5% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $4.94M -$601K -10.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $5.1M -$584K -10.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $5.25M -$570K -9.8% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $5.4M -$174K -3.12% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $5.54M -$156K -2.74% Jun 30, 2020 10-Q/A 2020-08-31
Q1 2020 $5.68M -$159K -2.72% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $5.82M +$3.42M +142% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $5.57M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $5.7M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $5.84M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $2.4M Jan 2, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.